NEWHALL CHARLES W III

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
NEWHALL CHARLES W III's trades of Supernus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
6.50
Quantity 858,235 +25.7%
Value US$5,578,528
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-10 2025-10-09
PlS Planned sale
80,912 +20.9%
324.95
US$3,433,079 		80,912 +20.9% 324.95 US$3,433,079
2025-10-10 2025-10-09
PlS Planned sale
12,466 -33.5%
60.53
US$645,748 		12,466 -33.5% 60.53 US$645,748
2025-10-09 2025-10-09
PrS Proposed sale
49,176
239.61
US$3,999,241 		49,176 239.61 US$3,999,241
2025-08-29 2025-08-27
PlS Planned sale
3,588 -2.7%
45.01
US$161,496 		3,588 -2.7% 45.01 US$161,496
2025-08-27 2025-08-25
PlS Planned sale
1,000 -0.7%
45.00
US$45,000 		1,000 -0.7% 45.00 US$45,000
2025-08-25 2025-08-25
PrS Proposed sale
4,588
44.88
US$205,909 		4,588 44.88 US$205,909
2025-08-26 2025-08-22
PlS Planned sale
1,412 -1.0%
45.00
US$63,540 		1,412 -1.0% 45.00 US$63,540
2025-08-22 2025-08-22
PrS Proposed sale
1,412
43.32
US$61,168 		1,412 43.32 US$61,168
2024-11-12 2024-11-11
PrS Proposed sale
10,700
36.24
US$387,775 		10,700 36.24 US$387,775
2024-11-12 2024-11-11
S Sale
10,700 -7.6%
36.24
US$387,768 		10,700 -7.6% 36.24 US$387,768
2023-11-20 2023-11-16
S Sale
2,500 -2.1%
28.01
US$70,025 		2,500 -2.1% 28.01 US$70,025
2023-11-16 2023-11-16
PrS Proposed sale
2,500
28.01
US$70,015 		2,500 28.01 US$70,015
2004-10-01 2004-09-29
B Purchase
858,235 +25.7%
6.50
US$5,578,528 		858,235 +25.7% 6.50 US$5,578,528